Login to Your Account



Xanthus Pharmaceuticals Inc.

Amonafide malate; an ATP independent tropoisomerase 2 inhibitor

To continue reading subscribe now to BioWorld Phase III Report

Learn More about BioWorld Phase III Report

Already a subscriber? Sign In or Buy now to activate your subscription